BIOMAT Database Logo BIOMAT Database Logo

Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse. 2010

Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Faculty of Medicine, Institute of Legal Medicine, University of Porto, Porto, Portugal. ricardinis@sapo.pt

Bruxism is a recognized side effect of several licit and illicit drugs. In this report, we illustrate this phenomenon in three patients suffering from 3,4-methylenedioxymethamphetamine (ecstasy) abuse.

UI MeSH Term Description Entries
D002012 Bruxism A disorder characterized by grinding and clenching of the teeth. Bruxomania,Teeth Grinding Disorder,Disorder, Teeth Grinding,Grinding Disorder, Teeth,Teeth Grinding Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D018490 Serotonin Agents Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. Serotonergic Agents,Serotonergic Drugs,Serotonin Drugs,Serotonin Effect,Serotonin Effects,Serotoninergic Effect,Serotoninergic Effects,Agents, Serotonergic,Agents, Serotonin,Drugs, Serotonergic,Drugs, Serotonin,Effect, Serotonin,Effect, Serotoninergic,Effects, Serotonin,Effects, Serotoninergic
D018817 N-Methyl-3,4-methylenedioxyamphetamine An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy. MDMA,Methylenedioxymethamphetamine,Ecstasy (Drug),N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride,Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine,N Methyl 3,4 methylenedioxyamphetamine,N Methyl 3,4 methylenedioxyamphetamine Hydrochloride
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.
January 1995, European neurology,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
[Recent abuse of 3,4-methylenedioxymethamphetamine ("yaoto-wang", "ecstasy")].
January 2002, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA).
February 1998, Acta crystallographica. Section C, Crystal structure communications,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
[Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
February 1995, Ugeskrift for laeger,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").
March 2003, The American journal of emergency medicine,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.
October 2012, Therapeutic drug monitoring,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology.
January 1999, The Journal of the American Board of Family Practice,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
November 2001, Journal of forensic sciences,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms.
July 2021, European journal of pharmacology,
Ricardo Jorge Dinis-Oliveira, and Inês Caldas, and Félix Carvalho, and Teresa Magalhães
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
August 1992, Lancet (London, England),
Copied contents to your clipboard!